| Susan E Gutierrez, MD | |
|
100 Park Pl, Suite 120, San Ramon, CA 94583-4460 | |
| (925) 806-0757 | |
| (925) 277-1557 |
| Full Name | Susan E Gutierrez |
|---|---|
| Gender | Female |
| Speciality | Interventional Pain Management |
| Experience | 25 Years |
| Location | 100 Park Pl, San Ramon, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518961127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | A86541 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Muir Medical Center - Concord Campus | Concord, CA | Hospital |
| Entity Name | Center For Pain And Rehabilitation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073104725 PECOS PAC ID: 1658763438 Enrollment ID: O20220128001305 |
News Archive
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.
The Small Business & Entrepreneurship Council (SBE Council) said the latest version of the Senate health care bill continues to ignore the plight of U.S. small businesses, and instead burdens them with additional taxes and regulations that will drive business costs higher.
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan E Gutierrez, MD 100 Park Pl, Suite 120, San Ramon, CA 94583-4460 Ph: (925) 806-0757 | Susan E Gutierrez, MD 100 Park Pl, Suite 120, San Ramon, CA 94583-4460 Ph: (925) 806-0757 |
News Archive
The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured a discussion by David Ewing Duncan titled "One Man's Quest for Personalized Medicine." Over the course of one year, Duncan submitted himself to hundreds of tests that could predict and even prevent future illness.
The Small Business & Entrepreneurship Council (SBE Council) said the latest version of the Senate health care bill continues to ignore the plight of U.S. small businesses, and instead burdens them with additional taxes and regulations that will drive business costs higher.
Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
› Verified 8 days ago